By slicing and dicing the data, the study confirms MITRA-FR as an outlier and emphasizes the need for careful patient selection.
PUNCH01: Interim results from a phase II study of intra-arterial chemotherapy (IAC) combined with tislelizumab and bacillus Calmette-Guerin (BCG) in high-risk non-muscle-invasive bladder cancer (HR ...
ImmunoCheckDB consists of three main functional modules: meta-analysis, network meta-analysis, and multiomics association analysis. The data collection, data overview, and specific applications of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results